Acquisition of SICM2022 catalogued medicines and its impact on the supply of medicines at the Riobamba Provincial General Teaching Hospital from 2022 to 2023.
DOI:
https://doi.org/10.55204/trc.v5i1.e449Keywords:
Drug Management, Hospital Supply, Pharmaceutical Inventory, Quality of Care, Health LogisticsAbstract
Introduction: Medical supply management has emerged as a critical challenge in contemporary healthcare systems, particularly in the wake of the profound impacts revealed by the COVID-19 pandemic. In this context, the study conducted at Riobamba Provincial General Teaching Hospital offers an innovative perspective on pharmaceutical supply optimization strategies.
Methods:Through a rigorous longitudinal descriptive quantitative analysis, the research examined 270 observations conducted between 2022 and 2023, utilizing advanced statistical tools that allowed a multidimensional understanding of management processes. Objetive: The fundamental objective was to evaluate the impact of new guidelines on drug availability, unraveling the dynamics that shape healthcare system efficiency.
Results: The results revealed a significant transformation. Drug availability experienced a substantial increase, moving from 4.73 to 7.17 months, accompanied by a notable reduction in stock rupture cases, from 48 to 19. A particularly relevant finding was the moderate correlation (r=0.68) between purchased quantity and availability, challenging traditional inventory management paradigms.
Conclusions: The findings underscore the importance of dynamic and adaptive purchasing strategies over maintaining high stock levels. The transformative impact of the ministerial guidelines was evident in the 51.58% increase in drug availability and a significant reduction in stock-outs.
Downloads
References
Al Harbi, S., Aljohani, B., Elmasry, L., Baldovino, F. L., Raviz, K. B., Altowairqi, L., & Alshlowi, S. (2024). Streamlining patient flow and enhancing operational efficiency through case management implementation. BMJ Open Quality, 13(1), e002484. https://doi.org/10.1136/bmjoq-2023-002484
Araujo, J. F. S. (2014). La gestión de abastecimiento de medicamentos en el sector público peruano: Nuevos modelos de gestión. 2(1).
Durán, C. E., & Naranjo, M. A. (2011). Caracteristicas de la compra de medicamentos en farmacias de Latacunga—Ecuador. Rev Fac Cien Med, 36, 17-22.
Guamán Lozano, A. G., Miño Cascante, G. E., Moyano Alulema, J. C. M., & García Flores, A. N. (2018). Mejoramiento del suministro de medicamentos para el instituto ecuatoriano de seguridad social. Revista Caribeña de Ciencias Sociales, 1-21.
Jiménez, A. J. G. (2019). Desabastecimiento de medicamentos esenciales en las unidades médicas de la red pública integral de salud en Ecuador Shortage of essential medicines in the medical units of the comprehensive public health network in Ecuador. 23.
Modisakeng, C., Matlala, M., Godman, B., & Meyer, J. C. (2020). Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Services Research, 20(1), 234. https://doi.org/10.1186/s12913-020-05080-1
Morris, P., & Sweeney, E. (2019). Responding to disruptions in the pharmaceutical supply chain. 1-22.
Muñoz-Solórzano, Y., & Chiriboga-Mendoza, F. (2023). Análisis de la gestión de las compras públicas en la economía local y latinoamericana, perspectivas sectoriales. Revista Científica Multidisciplinaria Arbitrada YACHASUN, 7(12). https://doi.org/10.46296/yc.v7i12edespmayo.0317
Ortiz-Prado, E., Galarza, C., Cornejo León, F., & Ponce, J. (2014). Acceso a medicamentos y situación del mercado farmacéutico en Ecuador. Rev Panam Salud Pública, 36(1), 57-62.
Patel, V., Cieslak, K., & Hertig, J. (2023). Improving Safety by Evaluating the Impact of the Supply Chain and Drug Shortages on Health-Systems. Hospital Pharmacy, 58(2), 120-124. https://doi.org/10.1177/00185787221126338
Reglamento a la Ley Orgánica Sistema Nacional Contratación Pública, 458 (2022).
Resolución No. R.E-SERCOP-2024-0140, R.E-SERCOP-2024-0140 1 (2024).
Seinfeld, J., & La Serna, K. (2007). Análisis económico de las compras públicas de medicamentos. Universidad del Pacífico, 1-64.
Shah, M. (2023). Drug Shortage—Impact on the supply of critical drugs. International Journal of Drug Regulatory Affairs, 11(3), 39-42. https://doi.org/10.22270/ijdra.v11i3.614
Suda, K. J., Callaway Kim, K., Hernandez, I., Gellad, W. F., Rothenberger, S., Campbell, A., Malliart, L., & Tadrous, M. (2022). The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis. Journal of the American Pharmacists Association, 62(3), 766-774.e6. https://doi.org/10.1016/j.japh.2021.12.014
Tobar, F. (2008). Lecciones aprendidas en la provisión de medicamentos para la atención primaria de la salud. Salud Pública de México, 50, S463-S469. https://doi.org/10.1590/S0036-36342008001000007
Tucker, E. L., & Daskin, M. S. (2022). Pharmaceutical supply chain reliability and effects on drug shortages. Computers & Industrial Engineering, 169, 108258. https://doi.org/10.1016/j.cie.2022.108258
Viñan, G. N. S., Caillagua, Y. C. S., Carrión, M. G. C., & Iñahuazo, J. F. I. (s. f.). Administración de medicamentos de alto riesgo asociado a la práctica de enfermería y circunstancias de errores en Ecuador. 4.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Bethzabe Abigail Borja Mendoza, Omar Patricio Negrete Costales
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
